kezar life sciences market cap
Thats a big deal for a clinical-stage biotech with a 600 million market cap at the time of this writing. This makes Kezar Life Sciences the worlds 5045th most valuable company by market cap according to our data.
Three Biotech Stocks You May Have Missed Equity Guru
View Kezar Life Sciences Incs Market Cap trends charts and more.
. Current Valuation vs Market Capitalization. Kezar Life Sciences Inc. Earnings for Kezar Life Sciences KZR Earnings in 2022 TTM.
Kezar Life Sciencess market cap is 2775 million. Historical Market Cap Data. View and export this data back to 2018.
Kezar Life Sciences stock was originally listed at a. Market capitalization or market value is the most commonly used method of measuring the size of a publicly traded. Market Cap 54491M.
Kezar Life Sciences market cap history and chart from 2017 to 2022. Kezar Life Sciences to Present Complete Results from the Phase 2 MISSION Trial of Zetomipzomib in. -6089 M According to Kezar Life Sciencess latest financial reports the companys current earnings TTM are -6089 MIn.
KZR IEX Real-Time Price USD 767-010 -129 Oct 7 2022 400 PM EDT - Market closed. Chiang served as Corporate Controller for Achaogen a publicly traded commercial-stage biopharmaceutical company from 2011 to 2018. Prior to joining Kezar in May 2018 Ms.
16 2021 0602 AM. 2 days agoKezar Life Sciences Inc. Return On Equity vs Market Capitalization.
59449M for July 25 2022. Kezar Life Sciences Inc. Find the latest Market Cap for Kezar Life Sciences KZR.
10 Day Average Volume 1. Kezar Life Sciences Inc. With Kezar Life Sciences stock trading at 851 per share the total value of Kezar Life Sciences stock market capitalization is 58182M.
NASDAQKZR shares are soaring Tuesday following a positive clinical readout. KZR a clinical-stage biotechnology company discovering and developing breakthrough treatments for immune-mediated and oncologic. Kezar Life Sciences fundamental comparison.
Market Cap is a widely used stock evaluation measure. Is a clinical-stage biopharmaceutical company that is focused on discovering. Kezar Announces Inducement Grant Under.
As of October 2022 Kezar Life Sciences has a market cap of 058 Billion. Kezar Life Sciences Market Cap. Shares of the clinical-stage biotech Kezar Life Sciences KZR-026.
Kezar Life Sciences fundamental comparison.
Why Kezar Life Sciences Stock Is Soaring Today The Motley Fool
Kezar Life Sciences Kzr Market Capitalization
Kezar Life Sciences Establishing New Paths For Treating Chronic Disease
Kezar Life Sciences Regulatory Tailwinds Reverse Downside Case Nasdaq Kzr Seeking Alpha
Kezar Life Sciences Kzr Stock Price Lots Of Optimism Surrounds Lupus Trial Results
Kzr Stock Forecast Price News Kezar Life Sciences
Kezar Life Sciences Stock Soars After Hours On Early Lupus Trial Data San Francisco Business Times
Kezar Slumps As Top Line Results From Zetomipzomib Trial Disappoint
Kezar Life Sciences Targeting The Immunoproteasome To Treat Autoimmunity Nasdaq Kzr Seeking Alpha
Etfs Holding Kzr Kezar Life Sciences Inc Etf Channel
Bpc Academy Intro To Biotech Trading Biopharmcatalyst
Kezar Life Sciences Key Catalysts Ahead Nasdaq Kzr Seeking Alpha
Kezar Life Sciences Inc Kzr Stock Price Us49372l1008 Marketscreener
Kezar Life Sciences Stock Quote Kzr Stock Price News Charts Message Board Trades
Latest News Kezar Life Sciences Inc Stock Kzr
Kezar Life Sciences Nasdaqgs Kzr Share Price News Analysis Simply Wall St
Are These The Best Small Cap Biotech Stocks To Watch This Week
Kzr Short Interest Kezar Life Sciences Inc Stock Short Squeeze Borrow Rates
Wall Street Analysts See An 82 Upside In Kezar Life Sciences Inc Kzr Can The Stock Really Move This High Nasdaq